Cloudy Peritoneal Fluid Attributable to Non-Dihydropyridine Calcium Channel Blocker

Peritoneal Dialysis International - Canada
doi 10.3747/pdi.2010.00277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Different Dihydropyridine Calcium Channel Blocker in Hypertensive Patients Who Developed Pedal Edema on Dihydropyridine Calcium Channel Blocker Therapy

Cumhuriyet Medical Journal
Medicine
2014English

Proischemic Complications of Dihydropyridine Calcium Channel Blockers

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Emergency Management of Calcium Channel Blocker Overdose

South African Medical Journal
Medicine
2019English

Extrapyramidal Symptoms After Exposure to Calcium Channel Blocker-Flunarizine or Cinnarizine

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

Positions of Calcium Channel Blocker Lercanidipine According to Evidence Based Cardiology

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2010English

Burn Scar Control With a Calcium Channel Blocker

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Hyperkalemia Induced by the Calcium Channel Blocker, Benidipine

Internal Medicine
Internal MedicineMedicine
2003English

Structural Studies of a New Dihydropyridine Calcium Channel Antagonist, Nilvadipine.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1986English

Metabolism of TC-81, a New Dihydropyridine Calcium Entry Blocker, in Rats and Dogs.

Drug Metabolism and Pharmacokinetics
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy